Trial Profile
Olanzapine for the Treatment of Post-Discharge Nausea and Vomiting After Ambulatory Surgery
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Jul 2020
Price :
$35
*
At a glance
- Drugs Olanzapine (Primary)
- Indications Postoperative nausea and vomiting
- Focus Therapeutic Use
- 06 Sep 2019 Status changed from recruiting to completed.
- 07 Mar 2017 Planned End Date changed from 1 Mar 2017 to 1 Dec 2020.
- 07 Mar 2017 Planned primary completion date changed from 1 Feb 2017 to 1 Dec 2020.